Cargando…

Cancer Genetics and Therapeutic Opportunities in Urologic Practice

This article aims to summarize the current literature on genetic alterations related to tumors of the genitourinary tract. Novel associations have recently been reported between specific DNA alterations and genitourinary malignancies. The most common cause of chromosome 3p loss in clear cell renal c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adashek, Jacob J., Leonard, Alex, Roszik, Jason, Menta, Arjun K., Genovese, Giannicola, Subbiah, Vivek, Msaouel, Pavlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140104/ https://www.ncbi.nlm.nih.gov/pubmed/32197306 http://dx.doi.org/10.3390/cancers12030710

Ejemplares similares

Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors
por: Adashek, Jacob J., et al.
Publicado: (2022)

Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?
por: Msaouel, Pavlos, et al.
Publicado: (2019)

Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?
por: Adashek, Jacob J., et al.
Publicado: (2020)

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
por: Msaouel, Pavlos, et al.
Publicado: (2020)

Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer
por: Adashek, Jacob J., et al.
Publicado: (2020)

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
por: Adashek, Jacob J., et al.
Publicado: (2021)

Genomics and Immunomics in the Treatment of Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2022)

Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
por: Grinshpun, Albert, et al.
Publicado: (2019)

Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2
por: Sarkar, Sanila, et al.
Publicado: (2023)

Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials
por: Hahn, Andrew W, et al.
Publicado: (2020)

Precision Oncology in Sarcomas: Divide and Conquer
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2019)

The abscopal effect in patients with cancer receiving immunotherapy
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2023)

Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2023)

On target methods to induce abscopal phenomenon for Off‐Target effects: From happenstance to happenings
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2022)

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021)

Caring for the caregiver: a systematic review characterising the experience of caregivers of older adults with advanced cancers
por: Adashek, Jacob J, et al.
Publicado: (2020)

Opportunities for Single-Cell Sequencing Technologies and Data Science
por: Mustachio, Lisa Maria, et al.
Publicado: (2020)

Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response
por: Persha, Hanna E., et al.
Publicado: (2022)

High-Throughput Architecture for Discovering Combination Cancer Therapeutics
por: Gianni, Matt, et al.
Publicado: (2018)

Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis
por: Msaouel, Pavlos, et al.
Publicado: (2011)

Practical urologic cytopathology /
por: Bardales, Ricardo H.
Publicado: (2002)

Benchmarking the Urology Practice
por: Brower, Paul A.
Publicado: (2008)

Urology in General Practice
por: Harvard, B. Marvin
Publicado: (1959)

The Principles and Practice of Urology
Publicado: (1935)

Urology in General Practice
Publicado: (1936)

Clinical application of the therapeutic ultrasound in urologic disease: Part II of therapeutic ultrasound in urology
por: Do, Minh-Tung, et al.
Publicado: (2022)

Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies
por: Kato, Shumei, et al.
Publicado: (2018)

Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
por: Wiele, Andrew J., et al.
Publicado: (2021)

Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma
por: Msaouel, Pavlos, et al.
Publicado: (2017)

Spermatozoal sensitive biomarkers to defective protaminosis and fragmented DNA
por: Angelopoulou, Roxani, et al.
Publicado: (2007)

Practical management of nocturia in urology
por: Jin, Myeong Heon, et al.
Publicado: (2008)

Market forces in urological practice
por: Karthikeyan, Vilvapathy Senguttuvan
Publicado: (2017)

Urology in India: Numbers and practice
por: Goel, Apul
Publicado: (2019)

Creating an Inclusive Urology Practice
por: Gonzalez, Gabriela, et al.
Publicado: (2023)

Understanding cavitation-related mechanism of therapeutic ultrasound in the field of urology: Part I of therapeutic ultrasound in urology
por: Cho, Sung Yong, et al.
Publicado: (2022)

Inferior Vena Cava in Urology: Importance of Developmental Abnormalities in Clinical Practice
por: Srivastava, Aneesh, et al.
Publicado: (2005)

Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
por: Salgia, Meghan, et al.
Publicado: (2017)

Single-Cell Sequencing: Current Applications in Precision Onco-Genomics and Cancer Therapeutics
por: Mustachio, Lisa Maria, et al.
Publicado: (2022)

Urovision 2020: The future of urology
por: Venkatramani, Vivek
Publicado: (2015)

The role of the insulin-like growth factor-1 system in breast cancer
por: Christopoulos, Panagiotis F, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ifjh4ma0ts5l6nsflk90genoqv